CyberLiver Ltd
AlcoChange is intended to reduce alcohol use and maintain abstinence in individuals with established alcohol-related liver disease (ArLD) and CirrhoCare is intended for assisted diagnosis, recommendations and therapeutic intervention for the management of new complications of decompensated cirrhosis.